Bernardlai
10-06

Great article, would you like to share it?

中信建投首次覆盖药师帮(9885.HK)给予“买入”评级：看好盈利能力提升

格隆汇9月8日｜9月5日，中信建投证券发布研究报告，首次覆盖药师帮并给予“买入”评级，看好其持续盈利能力和发展前景。2025年上半年，药师帮延续2024年扭亏为盈的强劲势头，实现营业收入、归母净利润分别为98.43亿元、0.78亿元，分别同比增长11.7%、258%，符合市场预期。其预计公司2025–2027年实现归母净利润分别为1.48亿元、3.15亿元和5.12亿元，分别同比增长393.6%、112.3%和62.7%，首次给予“买入”评级。该两家券商均维持“买入”评级。
中信建投首次覆盖药师帮(9885.HK)给予“买入”评级：看好盈利能力提升

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet